The Global Fund for HIV, TB, and Malaria reaffirms its commitment to introducing the twice-yearly HIV prevention jab, lenacapavir, in underprivileged countries.
The Trump administration's abrupt termination of USAID grants has jeopardised SA’s fight against HIV/AIDS, threatening health services and thousands of jobs.
Despite its promise, access to Lenacapavir, a revolutionary HIV prevention injection which stops 100% of new HIV infections in women and girls, is restricted.